rs10065321
|
SPRY4-AS1
|
Waist-Hip Ratio
|
|
0.700 |
GeneticVariation |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
rs10477176
|
SPRY4-AS1
|
Systolic Pressure
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Trans-ethnic association study of blood pressure determinants in over 750,000 individuals.
|
30578418 |
2019 |
rs153662
|
SPRY4-AS1
|
Body Height
|
|
0.700 |
GeneticVariation |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
rs2070715
|
FGF1;SPRY4-AS1
|
AIDS, PROGRESSION TO
|
C |
0.700 |
GeneticVariation |
GWASCAT |
Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy-Naive Participants From the Strategic Timing of AntiRetroviral Treatment Trial.
|
31219150 |
2019 |
rs2070715
|
FGF1;SPRY4-AS1
|
Viral Load result
|
C |
0.700 |
GeneticVariation |
GWASCAT |
Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy-Naive Participants From the Strategic Timing of AntiRetroviral Treatment Trial.
|
31219150 |
2019 |
rs2070715
|
FGF1;SPRY4-AS1
|
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
|
C |
0.700 |
GeneticVariation |
GWASCAT |
Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy-Naive Participants From the Strategic Timing of AntiRetroviral Treatment Trial.
|
31219150 |
2019 |
rs2070715
|
FGF1;SPRY4-AS1
|
HIV-1, RESISTANCE TO
|
C |
0.700 |
GeneticVariation |
GWASCAT |
Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy-Naive Participants From the Strategic Timing of AntiRetroviral Treatment Trial.
|
31219150 |
2019 |
rs2070715
|
FGF1;SPRY4-AS1
|
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
|
C |
0.700 |
GeneticVariation |
GWASCAT |
Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy-Naive Participants From the Strategic Timing of AntiRetroviral Treatment Trial.
|
31219150 |
2019 |
rs250100
|
FGF1;SPRY4-AS1
|
Body Height
|
|
0.700 |
GeneticVariation |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
rs253443
|
SPRY4-AS1
|
Red cell distribution width determination
|
|
0.700 |
GeneticVariation |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
rs253443
|
SPRY4-AS1
|
RDW - Red blood cell distribution width result
|
|
0.700 |
GeneticVariation |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
rs34000
|
FGF1;SPRY4-AS1
|
Waist-Hip Ratio
|
T |
0.700 |
GeneticVariation |
GWASCAT |
Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry.
|
30239722 |
2019 |
rs34000
|
FGF1;SPRY4-AS1
|
Waist-Hip Ratio
|
|
0.700 |
GeneticVariation |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
rs34427173
|
SPRY4-AS1
|
Body Height
|
|
0.700 |
GeneticVariation |
GWASCAT |
Characterizing rare and low-frequency height-associated variants in the Japanese population.
|
31562340 |
2019 |
rs76271629
|
SPRY4-AS1
|
Systolic Pressure
|
|
0.700 |
GeneticVariation |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
rs1650911
|
SPRY4-AS1
|
Systolic Pressure
|
G |
0.700 |
GeneticVariation |
GWASCAT |
Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits.
|
30224653 |
2018 |
rs249756
|
SPRY4-AS1
|
Low density lipoprotein cholesterol measurement
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Genetics of blood lipids among ~300,000 multi-ethnic participants of the Million Veteran Program.
|
30275531 |
2018 |
rs249767
|
SPRY4-AS1
|
Central corneal thickness
|
T |
0.700 |
GeneticVariation |
GWASCAT |
Cross-ancestry genome-wide association analysis of corneal thickness strengthens link between complex and Mendelian eye diseases.
|
29760442 |
2018 |
rs3853476
|
SPRY4-AS1
|
Systolic Pressure
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Interethnic analyses of blood pressure loci in populations of East Asian and European descent.
|
30487518 |
2018 |
rs3853476
|
SPRY4-AS1
|
Mean blood pressure
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Interethnic analyses of blood pressure loci in populations of East Asian and European descent.
|
30487518 |
2018 |
rs4244029
|
SPRY4-AS1
|
Low density lipoprotein cholesterol measurement
|
C |
0.700 |
GeneticVariation |
GWASCAT |
A large electronic-health-record-based genome-wide study of serum lipids.
|
29507422 |
2018 |
rs4244029
|
SPRY4-AS1
|
Serum total cholesterol measurement
|
C |
0.700 |
GeneticVariation |
GWASCAT |
A large electronic-health-record-based genome-wide study of serum lipids.
|
29507422 |
2018 |
rs152528
|
FGF1;SPRY4-AS1
|
Cardiac Hypertrophy
|
|
0.700 |
GeneticVariation |
GWASDB |
Hypertrophy-associated polymorphisms ascertained in a founder cohort applied to heart failure risk and mortality.
|
21348951 |
2011 |
rs152528
|
FGF1;SPRY4-AS1
|
Cardiomegaly
|
|
0.700 |
GeneticVariation |
GWASCAT |
Hypertrophy-associated polymorphisms ascertained in a founder cohort applied to heart failure risk and mortality.
|
21348951 |
2011 |
rs959662
|
SPRY4-AS1
|
Malignant Testicular Germ Cell Tumor
|
|
0.700 |
GeneticVariation |
GWASDB |
Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer.
|
20543847 |
2010 |